Economy

Crestwood Advisors Group LLC Grows Position in CVS Health Corporation (NYSE:CVS)

Crestwood Advisors Group LLC Grows Position in CVS Health Corporation (NYSE:CVS)”

Sei Investments Co.'s holdings in CVS Health Corporation were worth $32,735,000 as of its most recent SEC filing. 6,843 First of Long Island Corp (NASDAQ:FLIC) shares with value of $188,355 were sold by CURTIS MARK D. On Thursday, June 1 the insider VITTORIO MICHAEL N sold $49,541. Delta Cap Management has invested 1.62% in CVS Health Corp (NYSE:CVS).

Other institutional investors and hedge funds also recently bought and sold shares of the company.

The average 1-year price target for CVS Health Corporation (CVS) - averaging the work of different analysts - reveals a mean PT of $88.85/share.

Dnb Asset Management As says it decreased its stake in CVS Health Corporation by 251,100 shares in a 13F filing with the SEC. The Exchange Capital Management Inc holds 46,324 shares with $3.73 million value, down from 51,435 last quarter. California-based Mechanics Commercial Bank Trust Department has invested 1.03% in CVS Health Corp (NYSE:CVS). The Yhb Investment Advisors Inc holds 102,869 shares with $8.28M value, up from 93,047 last quarter. NY acquired a new stake in CVS Health Corporation in the 2nd quarter worth approximately $199,000. However it has a net margin of 2.90%.

The company now has an insider ownership of 0.1 Percent and Institutional ownership of 84.5 Percent. If you are viewing this article on another website, it was copied illegally and republished in violation of US & global trademark & copyright laws. Moreover, Dumont Blake Invest Lc has 0.57% invested in CVS Health Corp (NYSE:CVS).

CVS Health Corporation CVS began its day with a share price of 72.6.

The company's P/E ratio is 14.47 and the market cap of the company is 73.83B. CVS has recorded a 50-day average of $79.27 and a two hundred day average of $78.87. During the last 52 weeks, the (NYSE:CVS) price has been as high as $88.84 and as low as $69.3. CVS Health Corporation (CVS) has made its way to a 12-month decline of -17.5%. Analysts are forecasting earnings of $1.49 on a per share basis this quarter. The business had revenue of $45.69 billion during the quarter, compared to analysts' expectations of $45.36 billion. Moreno Evelyn V stated it has 2.33% in CVS Health Corp (NYSE:CVS). During the last 52 weeks, the price has been as high as $165.74 and as low as $110.33. They expect $0.16 earnings per share, up 33.33% or $0.04 from last year's $0.12 per share. They expect $0.46 EPS, up 70.37% or $0.19 from last year's $0.27 per share.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 3rd. CVS's SI was 24.69 million shares in October as released by FINRA. The ex-dividend date of this dividend is Monday, October 23rd. This dividend represents a yield of $2.46 which is the dividend as a percentage of the current share price. CVS Health Corporation's dividend payout ratio (DPR) is presently 39.92%. State Of New Jersey Common Pension Fund D holds 0.21% in CVS Health Corp (NYSE:CVS) or 649,943 shares. Sheets Smith Wealth Management now owns 9,171 shares of the pharmacy operator's stock worth $738,000 after acquiring an additional 55 shares during the period.

11/08/2016 - CVS Corporation had its "buy" rating reiterated by analysts at Mizuho. The shares were sold at an average price of $79.62, for a total value of $199,050.00. West Oak Capital, LLC now owns 19,455 shares worth $1,582,081,000. The disclosure for this sale can be found here. Its last month's stock price volatility remained 2.59% which for the week stands at 2.01%. The rating was maintained by Mizuho with "Buy" on Thursday, June 23. BidaskClub lowered CVS Health Corporation from a "hold" rating to a "sell" rating in a research report on Friday, August 25th. Finally, Jefferies Group LLC boosted their target price on CVS Health Corporation from $82.00 to $86.00 and gave the stock a "hold" rating in a report on Friday, September 15th. Deutsche Bank maintained it with "Hold" rating and $117 target in Wednesday, July 22 report. CVS Health had 43 analyst reports since July 22, 2015 according to SRatingsIntel. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and fourteen have given a buy rating to the company. Raymond James upgraded the stock to "Mkt Perform" rating in Tuesday, August 25 report. The Company delivers products and services by advising patients on their medications at its CVS Pharmacy locations; introducing programs for clients at CVS Caremark; delivering care to patients with complex conditions through CVS Specialty, and providing access to care at CVS MinuteClinic. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.



Like this

Latest


18 October 2017
Kenya election commissioner quits ahead of repeat presidential vote
Announcing his withdrawal, Odinga said: "All indications are that the election scheduled for 26 October will be worse than the previous one".

18 October 2017
City make it three out of three with win over Napoli
Sergio Aguero could return to bolster Manchester City as they look to take a giant stride towards the Champions League knockout phase.

18 October 2017
Plans to delist company stocks
The group's notice on Monday said companies with business activities violating USA federal law regarding marijuana could face a delisting review at the Toronto Stock Exchange.

18 October 2017
Daphne Caruana Galizia killed in Malta auto bomb blast
Some EU politicians are pressing for closer scrutiny of the tiny European Union nation in the Mediterranean Sea, which is considered a banking haven.

18 October 2017
Annual House Price Growth at 5% in August, Show Official Figures
These effects were partly offset by clothing prices that rose less strongly than this time previous year . Over the same period in London, property sales dropped by 20%, while in Wales, transactions rose by 1.4%.

18 October 2017
British terror threat 'the worst I've ever seen': MI5 director
He said continental Europe had faced a similar surge, particularly in France, Belgium, Germany and Spain. The agency, he added, was running 500 live operations involving 3,000 individuals.

18 October 2017
The Progressive Corporation (PGR) stock down -0.16% on volume of 3216581 shares
The target price per share would suggest a potential downside of -11.52 % from the last price of Progressive (NYSE:PGR). The forecast of 9 surveyed investment analysts covering the stock advises investors to Buy stake in the company.

18 October 2017
Australia's Crown hit by accusations of poker machine-fixing, shares tumble
This, Mr Wilkie said, meant "Crown would be facilitating money-laundering for crimes like tax fraud, drug-running and terrorism". Greens Senator Larissa Waters also helped start the campaign.

18 October 2017
52% Indians Say Military Rule Will be a Good Thing
It adds, "For example, in India, where the economy has grown on average by 6.9% since 2012, 85% trust their national government". However, in these countries the older population (aged 50 and above) have been the least supportive of military rule.

18 October 2017
Xi says China to significantly ease market access
Except for President Xi Jinping and Premier Li Keqiang, five of the seven members of the committee are set to retire. Such decisions will be formally announced at the end of the congress next week.



Recommended